Sabra Reports Third Quarter 2016 Results; Reports Earnings Per Share And FFO Per Share Growth Of 46% And 7%, Respectively, Over Third Quarter 2015

IRVINE, Calif., Nov. 02, 2016 (GLOBE NEWSWIRE) -- Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) (NASDAQ:SBRAP) today announced results of operations for the third quarter of 2016.

RECENT HIGHLIGHTS
  • For the third quarter of 2016, net income attributable to common stockholders, FFO, Normalized FFO, AFFO and Normalized AFFO per diluted common share were $0.35, $0.59, $0.54, $0.58 and $0.53, respectively, compared to $0.24, $0.55, $0.58, $0.53 and $0.53, respectively, for the third quarter of 2015.
  • During the third quarter of 2016, revenues increased 3% over the same period in 2015, from $59.9 million to $61.9 million.
  • During the third quarter of 2016, we made investments of $113.5 million with a weighted average initial cash yield of 7.9%.  These investments consisted of: (i) $109.6 million for one skilled nursing facility and three senior housing facilities; (ii) $0.7 million of preferred equity investments; and (iii) $3.2 million of investments in loans receivable.
  • During the third quarter of 2016, we sold a 135 bed skilled nursing facility for $10.0 million and recognized a gain on sale of $1.5 million. Also during the third quarter of 2016, we were repaid in full on two construction loans and a land loan totaling $17.3 million.
  • During the third quarter of 2016, we entered into three interest rate swap agreements to fix the LIBOR portion of the interest rate for our $245.0 million U.S. dollar term loan at 0.90% and to fix the CDOR portion on CAD $35.0 million of our Canadian dollar term loan at 0.93%. In addition, we terminated our five-year interest rate cap contract that capped LIBOR at 2.0% and received $0.3 million in connection with this termination.
  • On October 19, 2016, Moody's Investors Service affirmed all of Sabra's ratings, including the senior unsecured debt rating at Ba3, and revised our outlook to positive from stable, reflecting a significant reduction in our Genesis tenant concentration over the past two years as well as balance sheet improvement through a reduction in leverage.
  • On November 2, 2016, our board of directors declared a quarterly cash dividend of $0.42 per share of common stock. The dividend will be paid on November 30, 2016 to common stockholders of record as of the close of business on November 15, 2016.
  • On November 2, 2016, our board of directors declared a quarterly cash dividend of $0.4453125 per share of Series A Preferred Stock. The dividend will be paid on November 30, 2016 to preferred stockholders of record as of the close of business on November 15, 2016.

Commenting on the third quarter results and recent investments, Rick Matros, CEO and Chairman, said, "Sabra posted another solid quarter with a particularly strong showing in its Skilled Nursing/Transitional Care portfolio. Occupancy in that portfolio was slightly up, while skilled mix hit a new high of 43.7%. EBITDAR Coverage increased to 1.49x from 1.28x in the third quarter of 2015, while Genesis's Fixed Charge Coverage Ratio was steady at 1.24x as expected. We expect Genesis's Fixed Charge Coverage Ratio to be in that range for the foreseeable future and start ticking up in the latter part of 2017. Senior Housing coverage was down at 1.13x as it has been the last couple of quarters, which is primarily due to the incorporation of more recently acquired independent living facility (ILF) beds into our statistics as ILFs are underwritten at a lower coverage than assisted living or memory care. Same store coverage, which does not include ILF beds, was up at 1.36x. Senior Housing occupancy was down at 89.5% from 90.7% specifically due to two portfolios we acquired since mid-2015 whose performance was not included in our third quarter 2015 Facility Statistics as they had just been acquired. In the absence of these two portfolios, occupancy would have been 90.6%.

"During the three months ended September 30, 2016, we closed $113.5 million in investments at an average cash yield of just under 8.00%, bringing total investments for the year to $120.8 million at an average cap rate of 8.06%. The pipeline remains healthy at approximately $500.0 million, of which approximately 90.0% is Senior Housing facilities. We also reaffirm our previously issued earnings guidance."

TENANT COVERAGE
    EBITDAR (1)   EBITDARM (1)
    Twelve Months Ended September 30,
Facility Type   2016   2015   2016   2015
Skilled Nursing/Transitional Care   1.49x   1.28x   1.79x   1.62x
Senior Housing   1.13x   1.28x   1.29x   1.48x

    Twelve Months Ended September 30,
Fixed Charge Coverage Ratio (2)   2016   2015
Genesis Healthcare, Inc. (3)   1.24x   1.27x
Tenet Health Care Corporation   2.15x   2.44x
Holiday AL Holdings LP   1.17x   1.17x

(1) EBITDAR, EBITDARM and related coverages (collectively, "Facility Statistics") for each period presented include only Stabilized Facilities owned by the Company as of the end of the respective period. Facility Statistics are only included in periods subsequent to our acquisition. EBITDARM Coverage and EBITDAR Coverage exclude tenants with significant corporate guarantees. All Facility Statistics are presented one quarter in arrears.

(2) Fixed Charge Coverage Ratio is presented one quarter in arrears for tenants with significant corporate guarantees. See Reporting Definitions for definition of Fixed Charge Coverage Ratio.

(3) Fixed Charge Coverage Ratio for Genesis Healthcare, Inc. for the twelve months ended September 30, 2015 includes the pro forma impact of the Skilled Healthcare acquisition, which was completed on February 2, 2015.

LIQUIDITY

As of September 30, 2016, we had approximately $519.6 million of liquidity, consisting of unrestricted cash and cash equivalents of $19.6 million (excluding cash and cash equivalents associated with a RIDEA-compliant joint venture) and available borrowings of $500.0 million under our revolving credit facility.

CONFERENCE CALL AND COMPANY INFORMATION

A conference call and webcast to discuss the 2016 third quarter results will be held on Thursday, November 3, 2016 at 10:00 am Pacific Time. The dial in number for the conference call is (877) 879-6217 and the participant code is "SABRA." The webcast URL is  http://edge.media-server.com/m/p/y8chgy3v.  A replay of the call will also be available immediately following the call and for 30 days by dialing (888) 203-1112, and using pass code 8252769. The Company's supplemental information package for the third quarter will also be available on the Company's website in the "Investor Relations" section.

ABOUT SABRA

As of September 30, 2016, Sabra's investment portfolio included 182 real estate properties held for investment (consisting of (i) 102 Skilled Nursing/Transitional Care facilities, (ii) 79 Senior Housing facilities, and (iii) one Acute Care Hospital), 11 investments in loans receivable (consisting of (i) five mortgage loans, (ii) one construction loan, (iii) one mezzanine loan, (iv) three pre-development loans and (v) one debtor-in-possession ("DIP") loan), and 11 preferred equity investments. Included in the 182 real estate properties held for investment are two 100% owned Senior Housing facilities leased through RIDEA-compliant structures. As of September 30, 2016, Sabra's real estate properties held for investment included 18,632 beds/units, spread across the United States and Canada.

FORWARD-LOOKING STATEMENTS SAFE HARBOR

This release contains "forward-looking" statements as defined in the Private Securities Litigation Reform Act of 1995. These statements may be identified, without limitation, by the use of "expects," "believes," "intends," "should" or comparable terms or the negative thereof. Forward-looking statements in this release include all statements regarding our expectations concerning our future results of operations, future acquisition activity and future liquidity and concerning Genesis's Fixed Charge Coverage Ratio.

Our actual results may differ materially from those projected or contemplated by our forward-looking statements as a result of various factors, including among others, the following: our dependence on Genesis and certain wholly owned subsidiaries of Holiday AL Holdings LP until we are able to further diversify our portfolio; our dependence on the operating success of our tenants; the significant amount of and our ability to service our indebtedness; covenants in our debt agreements that may restrict our ability to pay dividends, make investments, incur additional indebtedness and refinance indebtedness on favorable terms; increases in market interest rates; changes in foreign currency exchange rates; our ability to raise capital through equity and debt financings; the impact of required regulatory approvals of transfers of healthcare properties; the effect of increasing healthcare regulation and enforcement on our tenants and the dependence of our tenants on reimbursement from governmental and other third-party payors; the relatively illiquid nature of real estate investments; competitive conditions in our industry; the loss of key management personnel or other employees; the impact of litigation and rising insurance costs on the business of our tenants; the effect of our tenants declaring bankruptcy or becoming insolvent; uninsured or underinsured losses affecting our properties and the possibility of environmental compliance costs and liabilities; the ownership limits and anti-takeover defenses in our governing documents and Maryland law, which may restrict change of control or business combination opportunities; the impact of a failure or security breach of information technology in our operations; our ability to find replacement tenants and the impact of unforeseen costs in acquiring new properties; our ability to maintain our status as a REIT; compliance with REIT requirements and certain tax and tax regulatory matters related to our status as a REIT; and other factors discussed from time to time in our news releases, public statements and/or filings with the Securities and Exchange Commission (the "SEC"), especially the "Risk Factors" sections of our Annual and Quarterly Reports on Forms 10-K and 10-Q. We do not intend, and we undertake no obligation, to update any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, unless required by law to do so.

TENANT AND BORROWER INFORMATION

This release includes information regarding certain of our tenants that lease properties from us and our borrowers, most of which are not subject to SEC reporting requirements. Genesis is subject to the reporting requirements of the SEC and is required to file with the SEC annual reports containing audited financial information and quarterly reports containing unaudited financial information. The information related to our tenants and borrowers that is provided in this release has been provided by such tenants and borrowers. We have not independently verified this information. We have no reason to believe that such information is inaccurate in any material respect. We are providing this data for informational purposes only. Genesis's filings with the SEC can be found at  www.sec.gov .

NOTE REGARDING NON-GAAP FINANCIAL MEASURES

This release includes the following financial measures defined as non-GAAP financial measures by the SEC: funds from operations attributable to common stockholders ("FFO"), Normalized FFO, Adjusted FFO ("AFFO"), Normalized AFFO, FFO per diluted common share, Normalized FFO per diluted common share, AFFO per diluted common share and Normalized AFFO per diluted common share. These measures may be different than non-GAAP financial measures used by other companies, and the presentation of these measures is not intended to be considered in isolation or as a substitute for financial information prepared and presented in accordance with U.S. generally accepted accounting principles. An explanation of these non-GAAP financial measures is included under "Reporting Definitions" in this release and reconciliations of these non-GAAP financial measures to the GAAP financial measures we consider most comparable are included under "Reconciliations of FFO, Normalized FFO, AFFO and Normalized AFFO" in this release.

SABRA HEALTH CARE REIT, INC.
 
FINANCIAL HIGHLIGHTS
 
(dollars in thousands, except per share data)
 
  Three Months Ended September 30,   Nine Months Ended September 30,
  2016   2015   2016   2015
Revenues $ 61,927     $ 59,934     $ 198,735     $ 172,092  
Net income attributable to common stockholders 22,776     15,500     39,419     46,664  
FFO attributable to common stockholders 38,427     35,644     123,706     93,732  
Normalized FFO attributable to common stockholders 35,446     38,014     116,975     101,849  
AFFO attributable to common stockholders 38,449     34,515     122,697     95,729  
Normalized AFFO attributable to common stockholders 34,978     34,515     113,060     96,184  
Per common share data attributable to common stockholders:              
Diluted EPS $ 0.35     $ 0.24     $ 0.60     $ 0.76  
Diluted FFO 0.59     0.55     1.89     1.52  
Diluted Normalized FFO 0.54     0.58     1.79     1.66  
Diluted AFFO 0.58     0.53     1.86     1.55  
Diluted Normalized AFFO 0.53     0.53     1.72     1.56  
               
Net cash flow from operations $ 39,322     $ 27,808     $ 133,816     $ 79,115  
               
Investment Portfolio September 30, 2016   December 31, 2015        
Real Estate Properties held for investment (1) 182     180          
Real Estate Properties held for investment, gross ($) $ 2,272,325     $ 2,277,158          
Total Beds/Units 18,632     18,349          
Weighted Average Remaining Lease Term (in months) 113     117          
Total Investments in Loans Receivable (#) 11     17          
Total Investments in Loans Receivable, gross ($) (2) $ 52,081     $ 271,094          
Total Preferred Equity Investments (#) 11     10          
Total Preferred Equity Investments, gross ($) $ 42,973     $ 29,993          
               
Debt September 30, 2016   December 31, 2015        
Principal Balance              
Fixed Rate Debt $ 865,045     $ 877,850          
Variable Rate Debt (3) 340,112     519,890          
Total Debt 1,205,157     1,397,740          
               
Cash (19,674 )   (7,434 )        
Net Debt (4) $ 1,185,483     $ 1,390,306          
               
Weighted Average Effective Rate              
Fixed Rate Debt 5.16 %   5.17 %        
Variable Rate Debt (3) 2.99 %   3.17 %        
Total Debt 4.55 %   4.43 %        
               
% of Total              
Fixed Rate Debt 71.8 %   62.8 %        
Variable Rate Debt (3) 28.2 %   37.2 %        
               
Availability Under Revolving Credit Facility $ 500,000     $ 195,000          
Available Liquidity (5) $ 519,588     $ 202,412          

(1)  Included in Real Estate Properties held for investment are two 100% owned Senior Housing facilities leased through RIDEA-compliant structures. (2)  Total Investments in Loans Receivable consists of principal plus capitalized origination fees net of loan loss reserves. (3)   As of September 30, 2016, variable rate debt includes $245.0 million subject to swap agreements that fix LIBOR at 0.90%, $68.5 million (CAD $90.0 million) and $26.6 million (CAD $35.0 million) subject to swap agreements that fix the CDOR rate at 1.59% and 0.93%, respectively. Excluding these amounts, there was no variable rate debt outstanding as of September 30, 2016. (4)   Net Debt excludes deferred financing costs and discounts. (5)  Available liquidity represents unrestricted cash, excluding cash associated with a consolidated joint venture, and availability under the revolving credit facility.
SABRA HEALTH CARE REIT, INC.
                               
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
                               
(dollars in thousands, except per share data)
   
  Three Months Ended September 30,   Nine Months Ended September 30,
  2016   2015   2016   2015
Revenues:              
Rental income $ 56,833     $ 53,173     $ 167,442     $ 152,574  
Interest and other income 3,157     6,211     25,482     17,594  
Resident fees and services 1,937     550     5,811     1,924  
               
Total revenues 61,927     59,934     198,735     172,092  
               
Expenses:              
Depreciation and amortization 17,102     16,306     51,273     44,953  
Interest 15,794     15,176     49,139     43,108  
Operating expenses 1,404     444     4,256     1,442  
General and administrative 6,171     3,547     15,521     19,270  
Provision for doubtful accounts and loan losses 540     2,489     3,286     6,605  
Impairment of real estate         29,811      
               
Total expenses 41,011     37,962     153,286     115,378  
               
Other income (expense):              
Loss on extinguishment of debt         (556 )    
Other income (expense) 2,945     (100 )   5,345     (300 )
Net gain (loss) on sale of real estate 1,451     (3,838 )   (3,203 )   (2,115 )
               
Total other income (expense) 4,396     (3,938 )   1,586     (2,415 )
               
Net income 25,312     18,034     47,035     54,299  
               
Net loss attributable to noncontrolling interests 25     27     66     47  
               
Net income attributable to Sabra Health Care REIT, Inc. 25,337     18,061     47,101     54,346  
               
Preferred stock dividends (2,561 )   (2,561 )   (7,682 )   (7,682 )
               
Net income attributable to common stockholders $ 22,776     $ 15,500     $ 39,419     $ 46,664  
               
Net income attributable to common stockholders, per:              
               
Basic common share $ 0.35     $ 0.24     $ 0.60     $ 0.76  
               
Diluted common share $ 0.35     $ 0.24     $ 0.60     $ 0.76  
               
Weighted-average number of common shares outstanding, basic 65,312,288     65,160,290     65,285,591     61,244,991  
               
Weighted-average number of common shares outstanding, diluted 65,591,428     65,398,175     65,470,589     61,468,603  
               

SABRA HEALTH CARE REIT, INC.
               
CONDENSED CONSOLIDATED BALANCE SHEETS
               
(dollars in thousands, except per share data)
   
  September 30, 2016   December 31, 2015
  (unaudited)    
Assets      
Real estate investments, net of accumulated depreciation of $272,953 and $237,841 as of September 30, 2016 and December 31, 2015, respectively $ 1,999,778     $ 2,039,616  
Loans receivable and other investments, net 94,466     300,177  
Cash and cash equivalents 19,674     7,434  
Restricted cash 9,150     9,813  
Prepaid expenses, deferred financing costs and other assets, net 116,353     111,797  
Total assets $ 2,239,421     $ 2,468,837  
       
Liabilities      
Mortgage notes, net $ 162,130     $ 174,846  
Revolving credit facility     255,000  
Term loans, net 337,641     264,229  
Senior unsecured notes, net 687,607     685,704  
Accounts payable and accrued liabilities 38,156     35,182  
Total liabilities 1,225,534     1,414,961  
       
Equity      
Preferred stock, $.01 par value; 10,000,000 shares authorized, 5,750,000 shares issued and outstanding as of September 30, 2016 and December 31, 2015 58     58  
Common stock, $.01 par value; 125,000,000 shares authorized, 65,259,836 and 65,182,335 shares issued and outstanding as of September 30, 2016 and December 31, 2015, respectively 653     652  
Additional paid-in capital 1,207,487     1,202,541  
Cumulative distributions in excess of net income (184,969 )   (142,148 )
Accumulated other comprehensive loss (9,382 )   (7,333 )
Total Sabra Health Care REIT, Inc. stockholders' equity 1,013,847     1,053,770  
Noncontrolling interests 40     106  
Total equity 1,013,887     1,053,876  
Total liabilities and equity $ 2,239,421     $ 2,468,837  
               

SABRA HEALTH CARE REIT, INC.
               
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
               
(in thousands)
               
  Nine Months Ended September 30,
  2016   2015
Cash flows from operating activities:      
Net income $ 47,035     $ 54,299  
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 51,273     44,953  
Non-cash interest income adjustments 549     343  
Amortization of deferred financing costs 3,767     3,829  
Stock-based compensation expense 6,137     5,389  
Amortization of debt discount 81     77  
Loss on extinguishment of debt 556      
Straight-line rental income adjustments (16,710 )   (18,272 )
Provision for doubtful accounts and loan losses 3,286     6,605  
Change in fair value of contingent consideration 50     300  
Net loss on sales of real estate 3,203     2,115  
Impairment of real estate 29,811      
Changes in operating assets and liabilities:      
Prepaid expenses and other assets 1,381     (15,035 )
Accounts payable and accrued liabilities 6,217     (2,410 )
Restricted cash (2,820 )   (3,078 )
Net cash provided by operating activities 133,816     79,115  
Cash flows from investing activities:              
Acquisitions of real estate (109,619 )   (386,572 )
Origination and fundings of loans receivable (9,478 )   (26,207 )
Origination and fundings of preferred equity investments (6,845 )   (9,281 )
Additions to real estate (901 )   (1,596 )
DIP loan fundings     (3,302 )
Repayment of loans receivable 214,947     3,285  
Release of contingent consideration held in escrow     5,240  
Net proceeds from the sale of real estate 85,449     15,752  
Net cash provided by (used in) investing activities 173,553     (402,681 )
Cash flows from financing activities:              
Net (repayments of) proceeds from revolving credit facility (255,000 )   136,000  
Proceeds from term loans 69,360     73,242  
Proceeds from mortgage notes     28,735  
Principal payments on mortgage notes (13,756 )   (2,184 )
Payments of deferred financing costs (5,933 )   (1,314 )
Issuance of common stock, net (1,289 )   139,617  
Dividends paid on common and preferred stock (89,283 )   (80,619 )
Net cash (used in) provided by financing activities (295,901 )   293,477  
               
Net increase (decrease) in cash and cash equivalents 11,468     (30,089 )
Effect of foreign currency translation on cash and cash equivalents 772     (231 )
Cash and cash equivalents, beginning of period 7,434     61,793  
       
Cash and cash equivalents, end of period $ 19,674     $ 31,473  
Supplemental disclosure of cash flow information:      
Interest paid $ 49,009     $ 43,405  
Supplemental disclosure of non-cash investing and financing activities:      
Assumption of mortgage indebtedness $     $ 19,677  
Real estate acquired through loan receivable foreclosure $ 10,100     $  
               

SABRA HEALTH CARE REIT, INC.
                               
RECONCILIATIONS OF FUNDS FROM OPERATIONS (FFO), NORMALIZED FFO,
                               
ADJUSTED FUNDS FROM OPERATIONS (AFFO) AND NORMALIZED AFFO
                               
(dollars in thousands, except per share data)
                               
  Three Months Ended September 30,   Nine Months Ended September 30,
  2016   2015   2016   2015
               
Net income attributable to common stockholders $ 22,776     $ 15,500     $ 39,419     $ 46,664  
Add:              
Depreciation of real estate assets 17,102     16,306     51,273     44,953  
Net (gain) loss on sales of real estate (1,451 )   3,838     3,203     2,115  
Impairment of real estate         29,811      
FFO attributable to common stockholders $ 38,427     $ 35,644     $ 123,706     $ 93,732  
Additional default interest income (582 )       (4,398 )    
Lease termination fee (2,634 )       (4,732 )    
Non-recurring or unusual acquisition pursuit costs 624         624     4,293  
Loss on extinguishment of debt         556      
(Recovery of) provision for doubtful accounts and loan losses, net (1) (13 )   2,370     1,847     3,369  
Other normalizing items (2) (376 )       (628 )   455  
Normalized FFO attributable to common stockholders $ 35,446     $ 38,014     $ 116,975     $ 101,849  
FFO $ 38,427     $ 35,644     $ 123,706     $ 93,732  
Acquisition pursuit costs 1,051     540     1,222     5,981  
Stock-based compensation expense 2,485     717     6,137     5,389  
Straight-line rental income adjustments (5,593 )   (6,438 )   (16,710 )   (18,272 )
Amortization of deferred financing costs 1,273     1,300     3,767     3,829  
Non-cash portion of loss on extinguishment of debt         556      
Change in fair value of contingent consideration 100     100     50     300  
Provision for doubtful straight-line rental income and loan losses 830     2,489     3,445     4,343  
Other non-cash adjustments (3) (124 )   163     524     427  
AFFO attributable to common stockholders $ 38,449     $ 34,515     $ 122,697     $ 95,729  
Additional default interest income (582 )       (4,398 )    
Lease termination fee (2,634 )       (4,732 )    
Recovery of doubtful cash income (1) (290 )       (290 )    
Other normalizing items (2) 35         (217 )   455  
Normalized AFFO attributable to common stockholders $ 34,978     $ 34,515     $ 113,060     $ 96,184  
Amounts per diluted common share attributable to common stockholders:              
Net income $ 0.35     $ 0.24     $ 0.60     $ 0.76  
FFO $ 0.59     $ 0.55     $ 1.89     $ 1.52  
Normalized FFO $ 0.54     $ 0.58     $ 1.79     $ 1.66  
AFFO $ 0.58     $ 0.53     $ 1.86     $ 1.55  
Normalized AFFO $ 0.53     $ 0.53     $ 1.72     $ 1.56  
Weighted average number of common shares outstanding, diluted:              
Net income, FFO and Normalized FFO 65,591,428     65,398,175     65,470,589     61,468,603  
AFFO and Normalized AFFO 65,872,688     65,528,033     65,854,782     61,641,797  

 

(1)  See Reporting Definitions for definition of Normalized FFO and Normalized AFFO for further information. (2)  Other normalizing items for FFO includes non-RIDEA facility operating expenses, ineffectiveness gain related to our LIBOR interest rate swaps and gain on sale of 48 skilled nursing beds. Other normalizing items for AFFO includes non-RIDEA facility operating expenses and gain on sale of 48 skilled nursing beds. (3)  Other non-cash adjustments includes amortization of debt premiums/discounts, non-cash interest income adjustments and amortization expense related to our interest rate hedges.

REPORTING DEFINITIONS

Acute Care Hospital. A facility designed to provide extended medical and rehabilitation care for patients who are clinically complex and have multiple acute or chronic conditions.

EBITDAR. Earnings before interest, taxes, depreciation, amortization and rent ("EBITDAR") for a particular facility accruing to the operator/tenant of the property (not the Company) for the period presented. The Company uses EBITDAR in determining EBITDAR Coverage. EBITDAR has limitations as an analytical tool. EBITDAR does not reflect historical cash expenditures or future cash requirements for facility capital expenditures or contractual commitments. In addition, EBITDAR does not represent a property's net income or cash flow from operations and should not be considered an alternative to those indicators. The Company utilizes EBITDAR as a supplemental measure of the ability of the Company's operators/tenants and relevant guarantors to generate sufficient liquidity to meet related obligations to the Company.

EBITDAR Coverage. Represents the ratio of EBITDAR to contractual rent for owned facilities. EBITDAR Coverage is a supplemental measure of an operator/tenant's ability to meet their cash rent and other obligations to the Company. However, its usefulness is limited by, among other things, the same factors that limit the usefulness of EBITDAR.

EBITDARM. Earnings before interest, taxes, depreciation, amortization, rent and management fees ("EBITDARM") for a particular facility accruing to the operator/tenant of the property (not the Company), for the period presented. The Company uses EBITDARM in determining EBITDARM Coverage. The usefulness of EBITDARM is limited by the same factors that limit the usefulness of EBITDAR. Together with EBITDAR, the Company utilizes EBITDARM to evaluate the core operations of the properties by eliminating management fees, which vary based on operator/tenant and its operating structure.

EBITDARM Coverage. Represents the ratio of EBITDARM to contractual rent for owned facilities. EBITDARM coverage is a supplemental measure of a property's ability to generate cash flows for the operator/tenant (not the Company) to meet the operator's/tenant's related cash rent and other obligations to the Company. However, its usefulness is limited by, among other things, the same factors that limit the usefulness of EBITDARM.

Fixed Charge Coverage Ratio. EBITDAR (including adjustments for one-time and pro forma items) for the period indicated (one quarter in arrears) for all operations of any entities that guarantee the tenants' lease obligations to the Company divided by the same period cash rent expense, interest expense and mandatory principal payments for operations of any entity that guarantees the tenants' lease obligation to the Company. Fixed Charge Coverage is a supplemental measure of a guarantor's ability to meet the operator/tenant's cash rent and other obligations to the Company should the operator/tenant be unable to do so itself. However, its usefulness is limited by, among other things, the same factors that limit the usefulness of EBITDAR. Fixed Charge Coverage is calculated by the Company as described above based on information provided by guarantors without independent verification by the Company and may differ from similar metrics calculated by the guarantors.

Funds From Operations Attributable to Common Stockholders ("FFO") and Adjusted Funds from Operations Attributable to Common Stockholders ("AFFO"). The Company believes that net income attributable to common stockholders as defined by GAAP is the most appropriate earnings measure. The Company also believes that Funds From Operations, or FFO, as defined in accordance with the definition used by the National Association of Real Estate Investment Trusts ("NAREIT"), and Adjusted Funds from Operations, or AFFO (and related per share amounts) are important non-GAAP supplemental measures of the Company's operating performance. Because the historical cost accounting convention used for real estate assets requires straight-line depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time. However, since real estate values have historically risen or fallen with market and other conditions, presentations of operating results for a real estate investment trust that uses historical cost accounting for depreciation could be less informative. Thus, NAREIT created FFO as a supplemental measure of operating performance for real estate investment trusts that excludes historical cost depreciation and amortization, among other items, from net income attributable to common stockholders, as defined by GAAP. FFO is defined as net income attributable to common stockholders, computed in accordance with GAAP, excluding gains or losses from real estate dispositions, plus real estate depreciation and amortization and real estate impairment charges. AFFO is defined as FFO excluding straight-line rental income adjustments, stock-based compensation expense, amortization of deferred financing costs, acquisition pursuit costs, as well as other non-cash revenue and expense items (including provisions and write-offs related to straight-line rental income, provision for loan losses, changes in fair value of contingent consideration, amortization of debt premiums/discounts and non-cash interest income adjustments). The Company believes that the use of FFO and AFFO (and the related per share amounts), combined with the required GAAP presentations, improves the understanding of the Company's operating results among investors and makes comparisons of operating results among real estate investment trusts more meaningful. The Company considers FFO and AFFO to be useful measures for reviewing comparative operating and financial performance because, by excluding the applicable items listed above, FFO and AFFO can help investors compare the operating performance of the Company between periods or as compared to other companies. While FFO and AFFO are relevant and widely used measures of operating performance of real estate investment trusts, they do not represent cash flows from operations or net income attributable to common stockholders as defined by GAAP and should not be considered an alternative to those measures in evaluating the Company's liquidity or operating performance. FFO and AFFO also do not consider the costs associated with capital expenditures related to the Company's real estate assets nor do they purport to be indicative of cash available to fund the Company's future cash requirements. Further, the Company's computation of FFO and AFFO may not be comparable to FFO and AFFO reported by other real estate investment trusts that do not define FFO in accordance with the current NAREIT definition or that interpret the current NAREIT definition or define AFFO differently than the Company does.

Investment. Represents the carrying amount of real estate assets after adding back accumulated depreciation and amortization.

Normalized FFO and Normalized AFFO. Normalized FFO and Normalized AFFO represent FFO and AFFO, respectively, adjusted for certain income and expense items that the Company does not believe are indicative of its ongoing operating results. The Company considers Normalized FFO and Normalized AFFO to be useful measures to evaluate the Company's operating results excluding these income and expense items to help investors compare the operating performance of the Company between periods or as compared to other companies. Normalized FFO and Normalized AFFO do not represent cash flows from operations or net income as defined by GAAP and should not be considered an alternative to those measures in evaluating the Company's liquidity or operating performance. Normalized FFO and Normalized AFFO also do not consider the costs associated with capital expenditures related to the Company's real estate assets nor do they purport to be indicative of cash available to fund the Company's future cash requirements. Further, the Company's computation of Normalized FFO and Normalized AFFO may not be comparable to Normalized FFO and Normalized AFFO reported by other REITs that do not define FFO in accordance with the current NAREIT definition or that interpret the current NAREIT definition or define FFO and AFFO or Normalized FFO and Normalized AFFO differently than the Company does. Prior to the third quarter of 2015, the Company normalized 100% of straight-line rental income write-offs.  In the third quarter of 2015, Sabra established a policy for normalizing write-offs and provisions for doubtful accounts to the extent in excess of any rental or interest income recognized during the period presented. The amounts for prior periods have been revised to conform to the current presentation.

Senior Housing. Senior housing facilities include independent living, assisted living, continuing care retirement community and memory care facilities.

Skilled Nursing/Transitional Care. Skilled nursing/transitional care facilities include skilled nursing, transitional care, multi-license designation and mental health facilities.

Stabilized Facility. At the time of acquisition, the Company classifies each facility as either stabilized or pre-stabilized. In addition, the Company may classify a facility as pre-stabilized after acquisition. Circumstances that could result in a facility being classified as pre-stabilized include newly completed developments, facilities undergoing major renovations or additions, facilities being repositioned or transitioned to new operators, and significant transitions within the tenants' business model. Such facilities will be reclassified to stabilized upon maintaining consistent occupancy (85% for Skilled Nursing/Transitional Care and 90% for Senior Housing Facilities) but in no event beyond 24 months after the date of classification as pre-stabilized. Stabilized Facilities exclude (i) facilities leased through RIDEA-compliant structures, (ii) facilities held for sale or being positioned to be sold, and (iii) facilities acquired during the three months preceding the period presented.

Total Debt. The carrying amount of the Company's revolving credit facility, term loan, senior unsecured notes, and mortgage indebtedness, as reported in the Company's condensed consolidated financial statements.
CONTACTInvestor & Media Inquiries: (949) 679-0410

Primary Logo

More from Press Releases

21st Century Fox Scoops Up Local News Stations

21st Century Fox Scoops Up Local News Stations

Walmart CEO: 'We Are Transforming Globally' With Flipkart

Walmart CEO: 'We Are Transforming Globally' With Flipkart

Three-Part FREE Webinar Series

Three-Part FREE Webinar Series

March 24 Full-Day Course Offering: Professional Approach to Trading SPX

March 24 Full-Day Course Offering: Professional Approach to Trading SPX

Meet the Real Money Pros: Market Strategies for 2012

Meet the Real Money Pros: Market Strategies for 2012